FSA Wealth Management’s Invesco Pharmaceuticals ETF PJP Stock Holding History

FSA Wealth Management’s Portfolio PJP Stock Details PJP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-62	Closed	-$4.96K	–	585
2025 Q2	$4.96K	Hold	62	–	–	﹤0.01%	384
2025 Q1	$5.36K	Hold	62	–	–	﹤0.01%	347
2024 Q4	$5.09K	Hold	62	–	–	﹤0.01%	384
2024 Q3	$5.35K	Buy	+62	New	+$5.3K	﹤0.01%	396
2024 Q1	$4.91K	Hold	61	–	–	﹤0.01%	451
2023 Q4	$5K	Buy	+61	New	+$4.36K	﹤0.01%	436

Other funds holding PJP

PAM

Peak Asset Management Louisville, Colorado $680M AUM 22.27% 1-Year Est. Return

LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

JGCM

Joseph Group Capital Management Columbus, Ohio $476M AUM 21.21% 1-Year Est. Return

MWM

MGB Wealth Management Addison, Texas $350M AUM 42.75% 1-Year Est. Return

Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return

FSA Wealth Management's PJP Position: Q3 2025 in Review

FSA Wealth Management sold out of Invesco Pharmaceuticals ETF (PJP) in Q3 2025, closing a stake of 62 shares — an estimated $4.96K sold.

FSA Wealth Management first reported a position in PJP in Q4 2023 and held it in 6 quarters. The position peaked at $5.36K in Q1 2025. 93 funds tracked by Wall St. Rank hold PJP as of Q3 2025.

FSA Wealth Management reported no remaining Invesco Pharmaceuticals ETF position as of Q3 2025 after selling out during the quarter.
FSA Wealth Management sold 62 Invesco Pharmaceuticals ETF shares in Q3 2025, an estimated $4.96K.
FSA Wealth Management first reported a position in Invesco Pharmaceuticals ETF in Q4 2023 and held it in 6 quarters.
FSA Wealth Management's Invesco Pharmaceuticals ETF position peaked at $5.36K in Q1 2025.
93 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2025.

Based on FSA Wealth Management's 13F filing for Q3 2025, filed 17 Nov 2025.